WASHINGTON, Sept. 6 /PRNewswire/ -- Media registration is now available
for BIO InvestorForum 2006, to be held October 18-19, 2006 at the Palace
Hotel in San Francisco. Hosted by the Biotechnology Industry Organization
(BIO), Rodman & Renshaw, Banc of America Securities, LLC, Jeffries &
Company, Inc., and RBC Capital Markets, the investor meeting will showcase
leading growth in companies in the life sciences.
"The BIO InvestorForum 2006 is the foremost gathering of biotech
industry executives and investors on the West Coast," stated Alan
Eisenberg, Executive Vice President, Emerging Companies and Business
Development. "Besides fantastic business opportunities, this meeting is an
invaluable opportunity for senior executives to come together to discuss
the latest issues and trends affecting the life sciences industry."
The meeting will feature select company presentations, dynamic panel
discussions and keynote talks on clinical strategy and product development
along with insights on exciting new therapies and investment opportunities
on the horizon. Focusing on growth potential for both public and private
companies, as well as the areas most likely to appear on the "growth watch
list" in 2007, this year's Therapeutic Workshops and CEO Roundtables
promise to explore hot topics and debate the challenges facing the
industry. In attendance will be institutional investors, hedge fund
managers, venture and private equity investors, as well as research
analysts and bankers representing leading banks in the sector.
Requested this year by sophisticated industry investors, the 2006
Therapeutic Workshop topics include:
* Designing the Next Successful Cancer Drug in a Competitive Landscape
* Redefining Alzheimer's Disease with the Rise of New Disease-Modifying
Drugs
* New Advances in Therapies for a Growing Diabetes Epidemic
* Evolving Treatments and Treatment Endpoints in Hepatitis C
* Stopping Heart Failure: The Promise of Current Research
* Valuing Molecular Diagnostics -- Today and in the Future
Based on popular demand, the slate of CEO Roundtable sessions this year
includes:
* The Next Biotech Winner: Investment Characteristics that May Improve
the Chances for Success in a High-Risk Industry
* Public Investors Crossing Over to Invest in Private Opportunities --
Separating Fact from Fiction
* Is M&A and Licensing Good for the Biotech Industry?
* Building Reimbursement Value Into Your Biotech Asset
Advance media registration for BIO InvestorForum 2006 is now available
online. Registration is complimentary for credentialed members of the news
media. To register, please visit
http://investorforum.bio.org/opencms/bif/2006/Registration/media.jsp. Only
reporters and editors working full-time for print or broadcast news
organizations may register onsite with valid media credentials. All
freelancers and online publications must register in advance by Friday,
October 6, 2006.
BIO represents more than 1,100 biotechnology companies, academic
institutions, state biotechnology centers and related organizations across
the United States and 31 other nations. BIO members are involved in the
research and development of healthcare, agricultural, industrial and
environmental biotechnology products.
SOURCE Biotechnology Industry Organization
 back to top
Related links:
http://www.bio.org
CONTACT:
Erin Reese of BIO, +1-202-962-9200
|
